2. Gene
  3. IL6 - interleukin 6 Gene

IL6 - interleukin 6 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：白细胞介素 6

种属: Felis catus

基因 ID: 493687 | 基因类型: protein coding

关于 IL6

IL6 基因产物(1)

mRNA Protein Name
NM_001009211.2 NP_001009211.2 interleukin-6 precursor

IL6 蛋白结构

IL6

IL6: pfam00489 (27 - 206)

  • 0
  • 100
  • 208 a.a.
蛋白主名 其他名称

interleukin-6

IL-6

interleukin 6 (interferon, beta 2)

相关产品

Approval
生物活性分子 (16)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B0260 Methylprednisolone 99.75% 是
HY-A0036 Bazedoxifene acetate Modulator 99.98% 是
HY-A0031 Bazedoxifene Modulator 99.06% 是
HY-B1402 Hydrocortisone hemisuccinate Inhibitor 99.83% 否
HY-B1350A Fusidic acid sodium salt Inhibitor 99.64% 是
HY-B0367 Lornoxicam 99.36% 否
HY-B0667 Balsalazide Inhibitor 99.34% 是
HY-B1402B Hydrocortisone hemisuccinate sodium Inhibitor 99.66% 否
HY-B0446 Naphazoline hydrochloride 98.12% 否
HY-B0513 Methylthiouracil Inhibitor ≥98.0% 否
HY-111326A Naphazoline nitrate ≥98.0% 否
HY-B0667A Balsalazide sodium hydrate Inhibitor 99.61% 是
HY-A0031A Bazedoxifene hydrochloride Modulator / 否
HY-111326 Naphazoline / 否
HY-B1402A Hydrocortisone hemisuccinate hydrate Inhibitor / 否
HY-B1402R Hydrocortisone hemisuccinate (Standard) / 否
抗体抑制剂 (6)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9917 Tocilizumab Antagonist 99.67% 否
HY-P9956 Siltuximab ≥99.0% 否
HY-P99165 Teprotumumab Inhibitor 99.46% 否
HY-P99111 Golimumab 99.71% 否
HY-P9916 Sarilumab Inhibitor 98.37% 否
HY-P99112 Satralizumab Inhibitor 99.82% 否
Clinical Phase
生物活性分子 (15)
目录号 产品名 作用方式
纯度 Phase
HY-114360AS1 Taurohyodeoxycholic acid-d4 sodium Inhibitor / Phase 4
HY-11109 Resatorvid Inhibitor 99.95% Phase 3
HY-146244 Agatolimod Agonist / Phase 3
HY-145564 Emprumapimod Inhibitor 99.12% Phase 3
HY-13740 Resiquimod 99.95% Phase 2
HY-113066A Guanosine 5'-diphosphate disodium salt Activator ≥99.0% Phase 2
HY-110133 JTE-607 Inhibitor 99.27% Phase 2
HY-147041 Selvigaltin Inhibitor 98.87% Phase 2
HY-15509A Semapimod tetrahydrochloride Inhibitor 98.43% Phase 2
HY-108039 Bezisterim Inhibitor ≥95.0% Phase 2
HY-113066C Guanosine 5'-diphosphate (sodium), 96% (HPLC) Activator 99.88% Phase 2
HY-113066 Guanosine 5'-diphosphate Activator / Phase 2
HY-107390 AX-024 Inhibitor 99.29% Phase 1
HY-107390A AX-024 hydrochloride Inhibitor 99.75% Phase 1
HY-P3412 MMI-0100 98.83% Phase 1
抗体抑制剂 (8)
目录号 产品名 作用方式
纯度 Phase
HY-P99316 Sirukumab Inhibitor 95.00% Phase 3
HY-P99210 Olokizumab Inhibitor 95.85% Phase 3
HY-P99252 Itolizumab ≥99.0% Phase 3
HY-P99505 Ziltivekimab Inhibitor 99.75% Phase 3
HY-P990012 Vamikibart Inhibitor ≥99.0% Phase 3
HY-P99012 Clazakizumab Inhibitor / Phase 3
HY-P99702 Levilimab Inhibitor / Phase 3
HY-P99385 Vobarilizumab Inhibitor 97.36% Phase 2
Pre-clinical Phase
生物活性分子 (242)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-102084 LMT-28 Inhibitor 98.93% 否
HY-N0560 Oroxylin A 99.87% 否
HY-141537 ABR-238901 Inhibitor 98.71% 否
HY-15614 SC144 98.50% 否
HY-100339 GSK583 Inhibitor 98.74% 否
HY-N0029 Forsythoside B 99.99% 否
HY-N0633 Muscone Inhibitor ≥98.0% 否
HY-W007376 Indole-3-carboxaldehyde 99.96% 否
HY-N0236 Corylin Inhibitor 99.97% 否
HY-19744 T6167923 Inhibitor 99.40% 否
HY-110126 AR-C118925XX Antagonist ≥99.0% 否
HY-N0405 Orientin Inhibitor 99.73% 否
HY-N0619 Mulberroside A Inhibitor 99.86% 否
HY-101448 TMI-1 99.59% 否
HY-100544 FLLL32 99.78% 否
HY-150738 ODN 2088 Antagonist 90.41% 否
HY-N1949 Homoplantaginin Inhibitor 99.90% 否
HY-B0141S1 Estradiol-d4 Agonist 99.55% 否
HY-N0710 alpha-Cyperone 99.80% 否
HY-19999A PF-CBP1 hydrochloride Inhibitor 99.99% 否
HY-N2007 Veratric acid Inhibitor 99.99% 否
HY-113509 Lipoxin A4 Inhibitor 99.19% 否
HY-N0569 Madecassic acid Inhibitor 99.79% 否
HY-N0604 Ginsenoside Rh1 Inhibitor ≥98.0% 否
HY-124750 NecroX-7 Inhibitor 99.69% 否
HY-N0897 Corylifol A Inhibitor 99.90% 否
HY-Y0148 10-Hydroxydecanoic acid Inhibitor 98.77% 否
HY-150738C ODN 2088 sodium Antagonist 90.41% 否
HY-15614A SC144 hydrochloride 99.34% 否
HY-N0314 Pectolinarin 99.89% 否
HY-113330 12S-HHT Agonist ≥99.0% 否
HY-N7674 Angoline Inhibitor 99.67% 否
HY-128598 MD2-TLR4-IN-1 Inhibitor 99.62% 否
HY-114360A Taurohyodeoxycholic acid sodium Inhibitor 99.60% 否
HY-152956 STING agonist-23 Agonist 99.16% 否
HY-N4288 4-Methylesculetin Inhibitor 98.21% 否
HY-N9965 2'-Fucosyllactose Inhibitor 99.95% 否
HY-113402A Gamma-glutamylcysteine TFA 95.20% 否
HY-N2086 Ethyl palmitate Inhibitor 99.05% 否
HY-N6246 Asperulosidic Acid Inhibitor 99.72% 否
HY-153190 W1131 99.25% 否
HY-P10284 S7 Antagonist 99.12% 否
HY-W082785A L6H21 99.46% 否
HY-150538 STAT3-IN-12 99.92% 否
HY-N1356 Reticuline Inhibitor 98.91% 否
HY-W041489 Chelidonic acid Inhibitor 99.91% 否
HY-113953 Z-Asp-CH2-DCB Inhibitor 99.64% 否
HY-N2572 Nepetin 99.51% 否
HY-N8146 Bruceantinol Inhibitor 98.89% 否
HY-145846 iNOs-IN-1 Inhibitor 99.83% 否
HY-B0141S Estradiol-d3 Agonist 98.60% 否
HY-112338 C188 Inhibitor ≥97.0% 否
HY-146066 α7 nAchR-JAK2-STAT3 agonist 1 99.54% 否
HY-126421 Kansuinine A Inhibitor 99.81% 否
HY-153254 BMS905 Inhibitor 99.59% 否
HY-B0260R Methylprednisolone (Standard) 99.67% 否
HY-23119 Sodium thiocyanate, GR, 99% 99.14% 否
HY-U00460 3,6-DMAD hydrochloride Inhibitor 99.50% 否
HY-N7275 Di-O-methyldemethoxycurcumin Inhibitor 97.64% 否
HY-N7652 Terminolic acid Inhibitor 99.63% 否
HY-148706 STAT3-IN-17 Inhibitor ≥98.0% 否
HY-150744A ODN 24888 sodium 93.10% 否
HY-N0857 Deoxyandrographolide Activator 99.87% 否
HY-N9315 Episappanol Inhibitor 98.57% 否
HY-13740S Resiquimod-d5 99.84% 否
HY-129113 α-​Chaconine Inhibitor 99.04% 否
HY-131688 2-Chlorohexadecanoic acid 99.88% 否
HY-150745 ODN 24987 Inhibitor 92.42% 否
HY-150745A ODN 24987 sodium 92.42% 否
HY-155335 FPR2 agonist 3 Agonist 99.39% 否
HY-B0141S2 Estradiol-d5 Agonist 99.88% 否
HY-N1940 β-Anhydroicaritin Inhibitor 99.09% 否
HY-N4126 6-Demethoxytangeretin Inhibitor 99.37% 否
HY-P0064 Palmitoyl Tetrapeptide-3 Inhibitor 99.20% 否
HY-P0317 Interleukin (IL)-6 Receptor 98.03% 否
HY-134353B ADP-β-S trilithium Activator 85.30% 否
HY-153190A W1131 TFA 99.27% 否
HY-125019 iJak-381 Inhibitor 99.86% 否
HY-146564A HP210 Modulator 98.96% 否
HY-152959 STING agonist-26 Agonist 99.56% 否
HY-156025 HCAR2 agonist 1 / 否
HY-B0260S3 Methylprednisolone-d7 99.73% 否
HY-N6927 Isoforskolin Inhibitor ≥98.0% 否
HY-P1117 MMK1 99.22% 否
HY-113066S2 Guanosine 5'-diphosphate-d13 dilithium Activator / 否
HY-115910A Y13g dihydrochloride Inhibitor 99.89% 否
HY-146564 R-HP210 98.21% 否
HY-147506 NOD2 antagonist 1 Antagonist 99.57% 否
HY-150744 ODN 24888 Inhibitor / 否
HY-151876 Glucocorticoid receptor modulator 1 99.79% 否
HY-153579 Anti-inflammatory agent 42 Inhibitor ≥98.0% 否
HY-169004 CBT-295 Inhibitor 99.34% 否
HY-B0141S3 Estradiol-d2 Agonist 99.44% 否
HY-N0569R Madecassic acid (Standard) Inhibitor / 否
HY-N0619A cis-Mulberroside A Inhibitor ≥96.0% 否
HY-N0811 Anemarsaponin B Inhibitor / 否
HY-N11768 4-Methoxylonchocarpin Inhibitor / 否
HY-N7674A Angoline hydrochloride Inhibitor / 否
HY-N8413 Chlojaponilactone B Inhibitor ≥98.0% 否
HY-103438 BIBU1361 / 否
HY-103438A BIBU1361 dihydrochloride / 否
HY-111077 INCB16562 Inhibitor / 否
HY-111164 CBS-3595 Inhibitor / 否
HY-113066B Guanosine 5'-diphosphate ditromethamine Activator / 否
HY-113066S1 Guanosine 5'-diphosphate-13C10 dilithium Activator / 否
HY-113066S3 Guanosine 5'-diphosphate-13C10,15N5 dilithium Activator / 否
HY-113509S Lipoxin A4-d5 Inhibitor / 否
HY-114592 M199 / 否
HY-115910 Y13g Inhibitor / 否
HY-115913 PDE4-IN-6 Inhibitor / 否
HY-115976 COX-2-IN-10 Inhibitor / 否
HY-116227 (2S,3R)-LP99 Inhibitor / 否
HY-122767 Romurtide Activator / 否
HY-123522 PAT-048 Inhibitor / 否
HY-126420 Kansuinine B Inhibitor ≥99.0% 否
HY-128423AS Tylvalosin-d9 / 否
HY-131668 9-POHSA / 否
HY-131934 9-OAHSA ≥99.0% 否
HY-134000 Emodic acid Inhibitor / 否
HY-134371 IL-17 modulator 2 Modulator / 否
HY-13559A Atiprimod dimaleate / 否
HY-143422 MALT1-IN-3 Inhibitor / 否
HY-143422A (R)-MALT1-IN-3 Inhibitor / 否
HY-146419 Anti-inflammatory agent 20 Inhibitor / 否
HY-146483 Anti-Aβ agent 1A Inhibitor / 否
HY-146547 Anti-inflammatory agent 17 Inhibitor / 否
HY-146561 S-HP210 Modulator 98.12% 否
HY-148238 GNE-2256 Inhibitor / 否
HY-149333 BO-1 Inhibitor / 否
HY-149391 PROTAC BTK Degrader-6 Degrader / 否
HY-149485 JNK2-IN-1 Inhibitor / 否
HY-149816 Anti-inflammatory agent 41 Inhibitor / 否
HY-149940 SIMR3030 Inhibitor / 否
HY-150740 ODN 21595 Inhibitor / 否
HY-150740A ODN 21595 sodium Inhibitor / 否
HY-152213 BET-IN-13 Inhibitor / 否
HY-152251 CB2R/FAAH modulator-1 / 否
HY-152957 STING agonist-24 Agonist / 否
HY-152958 STING agonist-25 Agonist / 否
HY-152961 STING agonist-28 Agonist / 否
HY-153330 TNF-α-IN-10 Inhibitor / 否
HY-155027 DPP-4-IN-8 Inhibitor / 否
HY-15509 Semapimod Inhibitor / 否
HY-155160 COX-2/15-LOX-IN-3 Inhibitor / 否
HY-155161 COX-2/15-LOX-IN-4 Inhibitor / 否
HY-155199 PDE1-IN-5 Inhibitor / 否
HY-155243 12R-LOX-IN-1 Inhibitor / 否
HY-155405 Anti-inflammatory agent 64 Inhibitor / 否
HY-155753 Anti-inflammatory agent 50 Inhibitor / 否
HY-155820 Anti-inflammatory agent 54 Inhibitor / 否
HY-155821 Anti-inflammatory agent 55 Inhibitor / 否
HY-156297 β5i-IN-1 Inhibitor / 否
HY-157546 VEGFR-2-IN-40 Inhibitor / 否
HY-157809 Anti-inflammatory agent 74 Inhibitor / 否
HY-157992 LM-021 Inhibitor / 否
HY-158434 IRAK1-IN-1 Inhibitor / 否
HY-159146 PPARα agonist 4 / 否
HY-159516 Sabialimon P Inhibitor / 否
HY-159891 Microtubule destabilizing agent-2 / 否
HY-160026 IL-17 modulator 8 Modulator / 否
HY-160028 IL-17 modulator 9 Modulator / 否
HY-160052 IL-6 aptamer sodium Chemical / 否
HY-160231 ssRNA42 sodium Activator / 否
HY-161240 MAO-B-IN-30 Inhibitor 98.53% 否
HY-161396 Anti-inflammatory agent 76 Inhibitor / 否
HY-161520 Glucocorticoid receptor/NF-κB modulator-1 / 否
HY-161620 DW18134 Inhibitor / 否
HY-161833 HSP90-IN-31 Inhibitor / 否
HY-161936 Z21115 Inhibitor / 否
HY-162122 PPARα/γ agonist 3 Agonist / 否
HY-162316 NF-κB-IN-15 Inhibitor / 否
HY-162622 BET-IN-26 Inhibitor / 否
HY-162641 AF-45 Inhibitor / 否
HY-162681 eeAChE-IN-3 Inhibitor / 否
HY-162797 PDE4-IN-18 Inhibitor / 否
HY-162963 PPARδ agonist 11 Agonist / 否
HY-163458 Anti-inflammatory agent 77 Inhibitor / 否
HY-163670 TLR7 agonist 21 Inhibitor / 否
HY-163748 GSK-3β inhibitor 17 Inhibitor / 否
HY-163755 GPER activator 1 / 否
HY-163777 Talaroterphenyl A Inhibitor / 否
HY-163848 Anti-inflammatory agent 90 / 否
HY-163998 TLR4-IN-1 / 否
HY-168084 IL-17-IN-1 Inhibitor / 否
HY-168340 COX-2/15-LOX-IN-6 Inhibitor / 否
HY-168709 Nrf2 activator 18 Activator / 否
HY-168734 CB2 receptor agonist 9 Agonist / 否
HY-169402 PDE1-IN-9 Inhibitor / 否
HY-169417 Euphjatrophane M Inhibitor / 否
HY-169420 IL-6-IN-1 Inhibitor / 否
HY-19606 Cytogenin Inhibitor / 否
HY-A0031S Bazedoxifene-d4 Modulator / 否
HY-A0031S2 Bazedoxifene-d4 acetate / 否
HY-B0141S4 Estradiol-13C6 Agonist / 否
HY-B0141S5 Estradiol-13C2 Agonist / 否
HY-B0141S6 Estradiol-d2-1 Agonist / 否
HY-B0260S Methylprednisolone-d3 / 否
HY-B0260S2 Methylprednisolone-d4 / 否
HY-B0260S4 Methylprednisolone-d2 / 否
HY-B0667S1 Balsalazide-d4 Inhibitor / 否
HY-N0604R Ginsenoside Rh1 (Standard) Inhibitor / 否
HY-N0976 1,11b-Dihydro-11b-hydroxymedicarpin / 否
HY-N12042 Taxamairin B Inhibitor / 否
HY-N12743 Farobin A Inhibitor / 否
HY-N13114 8-Gingerdione / 否
HY-N2007S Veratric acid-d6 Inhibitor / 否
HY-N3380 Linderaspirone A Inhibitor / 否
HY-N3421 Koaburaside Inhibitor / 否
HY-N3552 Catalposide Inhibitor ≥98.0% 否
HY-N4061 Hedycoronen A Inhibitor / 否
HY-N7630 Rehmapicrogenin Inhibitor / 否
HY-N8107 Matairesinol monoglucoside Inhibitor / 否
HY-N8936 Narchinol B / 否
HY-N9891 12-Dehydrogingerdione Inhibitor / 否
HY-P10350 PapRIV Agonist / 否
HY-P10710 BMP-4 Inhibitor / 否
HY-P10796 YARA peptide Inhibitor / 否
HY-P1117A MMK1 TFA / 否
HY-P5836 Citrullinated LL-37 1cit Inhibitor / 否
HY-P5837 Citrullinated LL-37 2cit Inhibitor / 否
HY-RS06774 IL6 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS06775 Il6 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS06776 Il6 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS06777 IL6R Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS06778 IL6ST Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-U00460B 3,6-DMAD dihydrochloride Inhibitor / 否
HY-W1000105 Geranial Inhibitor / 否
HY-101410A SDMA (p-hydroxyazobenzene-p′-sulfonate) / 否
HY-107338 Denotivir Inhibitor / 否
HY-110133A JTE-607 free base Inhibitor / 否
HY-113545 9(R)-HODE / 否
HY-118312 CAY10657 Inhibitor / 否
HY-123625 R-348 choline Inhibitor / 否
HY-124613 Pyrazinib Inhibitor / 否
HY-126758 Ludartin Inhibitor / 否
HY-146066A (R)-α7 nAchR-JAK2-STAT3 agonist 1 / 否
HY-167939 (R)-Bambuterol / 否
HY-171034 PQA-18 Inhibitor / 否
HY-N13202 Black Currant Extract / 否
HY-N9541 Chaetoglobosin Vb / 否
HY-W505984 TPNA10168 Activator / 否
HY-W923189 Neral Inhibitor / 否
抗体抑制剂 (7)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990008 Atrosab 98.00% 否
HY-P99287 Elsilimomab Inhibitor 98.44% 否
HY-P990212 Anti-Mouse IL-6 Antibody (MP5-20F3) Inhibitor 99.20% 否
HY-P99336 Enlimomab Inhibitor 95.00% 否
HY-P990211 Anti-Mouse IL-6R Antibody (15A7) Inhibitor 95.00% 否
HY-P990937 Pacibekitug Inhibitor / 否
HY-P991030 Tabirafusp alfa Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens IL6 NCBI NCBI:3569
Macaca fascicularis IL6 NCBI NCBI:102138971
Mus musculus IL6 NCBI NCBI:16193
Rattus norvegicus IL6 NCBI NCBI:24498
Macaca mulatta IL6 NCBI NCBI:705819
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z